Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» polyarticular juvenile idiopathic arthritis
polyarticular juvenile idiopathic arthritis
Janssen’s Simponi Aria Gains Extended FDA Approvals for Rare Children’s Arthritis Conditions
Xtalks
Tue, 10/6/20 - 11:19 pm
Janssen
JNJ
Simponi Aria
polyarticular juvenile idiopathic arthritis
FDA
Pfizer gets FDA nod for Xeljanz to treat juvenile idiopathic arthritis
Pharmaceutical Business Review
Tue, 09/29/20 - 11:56 am
Pfizer
Xeljanz
FDA
polyarticular juvenile idiopathic arthritis
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
Mon, 04/27/20 - 09:29 am
JNJ
Janssen
FDA
Simponi Aria
polyarticular juvenile idiopathic arthritis
juvenile psoriatic arthritis